The Cell Panel Screening service is suitable for testing the therapeutic efficacy of test compounds on different human cancer cell lines from across >20 tumor types.
Solved problem:
Identify the sensitive tumor cell lines
Identify the susceptible cancer types
Identify the most responsive tumor cell lines for subsequent studies on cellular models or animal studies
Identify the genomic signature of your drug for the prediction of anticancer drug response (Option)
Cell Panel Screening _Classification
Customized cell panel:
500+ human tumor cell lines in ICE cell bank (will add 50 cell lines/month)
The client could choose any cell lines in ICE cell bank for testing
Fixed cell panel screening:
170 tumor cell lines from across 21 tumor types


Cell Panel Screening_Assay Setup
Controls Setup:
High control: DMSO only
Low control: Medium only
Reference compound: Staurosporine, the IC50 value will be provided
Report:
Signature, Summary, materials and instruments, Protocol, Compound dilution, Plate Map, Raw data and result of IC50, as well as IC50 summary for each analysis will be provided.
Compound requirements:
In brief: 100 µL of the stock solution with 1000× the highest testing concentration or the equivalent as solid material.
Could support biomarker and protein degradation analysis (options)
Cell Panel Screening_Assay Discription
Cells were seeded in 384 well pate.
After overnight, compounds are dispensed by a ECHO machine.
Cells are treated at 37 ℃ at 5 % CO2.
CellTiter-Gio dection.

Ref (Staurosporine) reproducibility

General Human cancer cell panel_Detection method

Cell Panel Screening _Turnaround time (CTG)
<20 cell="" lines:="" 1-2="" weeks="">
20~30 cell lines: 2-3 weeks
30~40 cell lines: 3-4 weeks
40~50 cell lines: 4-5 weeks
100 Cell Panel: 6-7 weeks
100 Cell Panel: 6-7 weeks
150 Cell Panel: 7-8 weeks
200 Cell Panel: 8-9 weeks
170 fixed Cell Panel: 7-8 weeks (RBC_160 Cell panel_5-6 weeks)
ICE_CP170 Cell Panel Screening
The ICE_CP170 cell panel screening provides efficacy data for 170 tumor cell lines from across 21 tumor types.

170 Cell Panel Screening_Advantages
Performed on at any time
Huge cost-savings
Fast turnaround time
Reproducible data
Single drug or combination drug testing
Option for in-depth bioinformatics analysis
Quote

We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Get a quote
Go top